S. Mert Selimoglu, PhD

Pakmaya, Pak Group of Companies

He has an academic background in the generation and production of whole and recombinant antibodies via classic hybridoma technique and synthetic biology techniques, using phage display. Since 2016, he has been working in the R&D of a food biotechnology company with the role of industrial cell line and bioprocess development.

Phage cocktail-based COVID-19 vaccine may have potential for much longer-term efficacy This week, we're featuring an opinion piece by Dr. Mert Selimoglu (Pakmaya, Turkey) on phage-based COVID vaccines, and the opportunity he sees for using a phage library/cocktail approach to make more effective vaccines. 122.Apr 16, 2021S. Mert Selimoglu